Annual Total Debt
$12.50 M
-$7.43 M-37.29%
December 31, 2023
Summary
- As of February 8, 2025, XLO annual total debt is $12.50 million, with the most recent change of -$7.43 million (-37.29%) on December 31, 2023.
- During the last 3 years, XLO annual total debt has fallen by -$8.71 million (-41.07%).
- XLO annual total debt is now -41.07% below its all-time high of $21.22 million, reached on December 31, 2020.
Performance
XLO Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$8.41 M
-$267.00 K-3.08%
September 30, 2024
Summary
- As of February 8, 2025, XLO quarterly total debt is $8.41 million, with the most recent change of -$267.00 thousand (-3.08%) on September 30, 2024.
- Over the past year, XLO quarterly total debt has dropped by -$4.09 million (-32.70%).
- XLO quarterly total debt is now -60.34% below its all-time high of $21.22 million, reached on December 31, 2020.
Performance
XLO Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
XLO Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.3% | -32.7% |
| 3 y3 years | -41.1% | -32.7% |
| 5 y5 years | +100.0% | -32.7% |
XLO Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -39.1% | at low | -59.0% | at low |
| 5 y | 5-year | -41.1% | at low | -60.3% | -100.0% |
| alltime | all time | -41.1% | -100.0% | -60.3% | -100.0% |
Xilio Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $8.41 M(-3.1%) |
| Jun 2024 | - | $8.68 M(-2.9%) |
| Mar 2024 | - | $8.94 M(-28.5%) |
| Dec 2023 | $12.50 M(-37.3%) | $12.50 M(-13.1%) |
| Sep 2023 | - | $14.39 M(-14.4%) |
| Jun 2023 | - | $16.81 M(-7.2%) |
| Mar 2023 | - | $18.11 M(-9.2%) |
| Dec 2022 | $19.94 M | $19.94 M(-0.8%) |
| Sep 2022 | - | $20.10 M(-0.7%) |
| Jun 2022 | - | $20.25 M(-0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $20.40 M(-0.7%) |
| Dec 2021 | $20.54 M(-3.2%) | $20.54 M(-0.6%) |
| Sep 2021 | - | $20.67 M(-0.4%) |
| Jun 2021 | - | $20.75 M(>+9900.0%) |
| Mar 2021 | - | $0.00(-100.0%) |
| Dec 2020 | $21.22 M(+13.9%) | $21.22 M(>+9900.0%) |
| Sep 2020 | - | $0.00 |
| Dec 2019 | $18.63 M(>+9900.0%) | - |
| Dec 2018 | $0.00(0.0%) | - |
| Dec 2017 | $0.00(0.0%) | - |
| Dec 2016 | $0.00 | - |
FAQ
- What is Xilio Therapeutics annual total debt?
- What is the all time high annual total debt for Xilio Therapeutics?
- What is Xilio Therapeutics annual total debt year-on-year change?
- What is Xilio Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Xilio Therapeutics?
- What is Xilio Therapeutics quarterly total debt year-on-year change?
What is Xilio Therapeutics annual total debt?
The current annual total debt of XLO is $12.50 M
What is the all time high annual total debt for Xilio Therapeutics?
Xilio Therapeutics all-time high annual total debt is $21.22 M
What is Xilio Therapeutics annual total debt year-on-year change?
Over the past year, XLO annual total debt has changed by -$7.43 M (-37.29%)
What is Xilio Therapeutics quarterly total debt?
The current quarterly total debt of XLO is $8.41 M
What is the all time high quarterly total debt for Xilio Therapeutics?
Xilio Therapeutics all-time high quarterly total debt is $21.22 M
What is Xilio Therapeutics quarterly total debt year-on-year change?
Over the past year, XLO quarterly total debt has changed by -$4.09 M (-32.70%)